Life Sciences

World Markets Healthcare

Identify the next growth opportunity

Can you keep pace with shifting policy and market dynamics? Need to optimize your growth strategy? Do you know the competitive landscape for a particular product? Do you need a healthcare market overview?

This forecasting and analytical tool provides the most comprehensive and up-to-date global outlook for the pharmaceutical industry. Quantitative, quarterly-updated forecasts for healthcare and pharmaceutical sales are supplemented with daily analysis of significant global healthcare developments that drive the global sector, as well as country reports, special reports, and bulletins. Seamlessly analyze changes in the regulatory and business landscape to:

Rank and size markets
Plan budgets and sales with great accuracy
Hedge exposure to market risk
Optimize R&D processes
Secure market access and grow your business
Monitor business development opportunities and activities
Strengthen competitive intelligence

View global sales phone numbers Email

Alzheimer's and dementia treatment a USD1 trillion market

Follow latest R&D trends and prospects

Download now

Impact of Brexit on Healthcare

Read our strategic report

Download now

What’s Included

Analysis and Data

Headline Analysis

Global daily coverage of all key events affecting the operating environment for pharma companies, customizable by country, sector, topic and therapeutic area

Special Reports
Global and regional industry/market trends, therapeutic area news, biosimilars and generics developments, mergers and acquisitions and licensing activity, private insurance markets, and executive briefings on key global developments

Biosimilars
Database of approved and pipeline biosimilars

Country Reports
In-depth country reports for 70 countries, covering these topics:

Healthcare spending and pharmaceuticals sales forecasts
SWOT analysis
Demographic projections and disease trends
Health system infrastructure overview
Financing of health care provision
Marketing authorization process and IP protection legislation
Major legislative, regulatory and expenditure reforms
Pharmaceutical market structure and outlook

Click to enlarge

Country Forecasts

Derived from world-renowned economic modeling, including:

Ten-year expenditure and sales forecasts (70 countries)
Top-line SWOT tables
Executive briefings on forecast updates

Country Coverage

Global country coverage in daily analysis, supplemented by in-depth country reports for:

Sub-Saharan Africa

Ghana
Kenya
Nigeria
South Africa
Uganda

Middle East/North Africa

Algeria
Egypt
Iran
Israel
Jordan
Kenya
Lebanon
Saudi Arabia
UAE

Asia Pacific

Australia
China
Hong Kong
India
Indonesia
Japan
Kazakhstan
Malaysia
New Zealand
Pakistan
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe

Austria
Belgium
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom

North America

Canada
Mexico
United States

Latin America and Caribbean

Argentina
Brazil
Chile
Colombia
Cuba
Peru
Venezuela

Data Indicators

Healthcare Expenditure
- Public
- Private

Pharmaceutical Sales (LCU)
- By brand status: Originator; Generic
- By Prescription status: Prescription; Non-Prescription
- By Retail or Hospital Status
- By Therapy Area – ATC Level 1

Pharmaceutical Goods Trade Balance
- Exports
- Imports

Population by Age (0-4; 5-9; 0-14; 15-64; 65+)
- Male
- Female

Index of fertility/life expectancy

Price Deflators
- Consumer Price Inflation
- Gross Domestic Product
- Medical Price Deflator

Click to enlarge

Member Privileges

Analyst Access
On-demand access to our analysts, economists, and industry experts

Webcasts
Email invitations to Life Science webcasts hosted by our experts

Delivery Options

Connect^®
Maximize your subscription content with Connect – our state-of-the-art business intelligence platform

Understand pharma/healthcare trends instantly with new dynamic charts, heatmaps and ranking tables
Get a global market overview with a new healthcare homepage
See all content and data for individual markets with new country pages
Save, reconfigure and export charts
Generate your regular pdf and Word deliverables using Report Builder
Synchronize and transform forecast data
Set up your preferred geographic regions
Precisely tailor email alerts

REST API
Our API delivers data continuously and reliably directly into your workflow.

Representational State Transfer Application Programming (REST) API makes data available via URL addresses (or ‘endpoints’)
Provides a foundation on which to build databases, charts, websites, visualizations and CSV files, plus facilities to query and lookup specific data
Offers the simplest approach to application integration:
- Access to the API is instantaneous
- Provides an interactive web environment for developers to explore API features and review technical documentation
- Developers can test the API calls interactively in a browser
24/7 monitoring and support is provided
Scales horizontally for both datasets and clients, ensuring it can meet present and future demand
Built for consistent speed, with carefully selected technologies to ensure the best possible performance

IDDS
IDDS offers tailored data feeds featuring continuous updating and seamless delivery.

Internet Data Delivery System (IDDS) delivers fixed data updates in CSV or XML format to the IHS Markit web servers in real time
Metadata includes economic concept, geography, source and frequency
Updates pull in data changes only, optimizing load speed
Data updates can be scheduled

Solve Your Business Challenge

Challenge	Solution
I need to rank and size markets to set a strategic growth plan.	Use our healthcare and pharma forecasts to assess opportunities and risks, as well as our headline analysis to understand the latest market developments
How can I easily monitor multiple sources to keep pace with healthcare market trends?	Leverage our headline analysis to monitor competitors, R&D, investments, partnerships and regulatory issues.
I need to get a quick and accurate picture of a particular market.	Our SWOT tables, integrated into our country reports, provide a complete market overview, helping you plan with confidence.
I need to hedge my exposure in a contracting market.	Leverage forecasts to plan sales and budgets with greater accuracy. Distill our analysis and historical data to understand healthcare market drivers country-wide.
Generics and biosimilars are changing my market dynamics. How do I stay on top of these changes?	Access detailed data on the generics and biosimilars market, including pipeline and approved drugs.

Experts

4 Experts

Gustav Ando

Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and new treatment advances as well as coordinating its ongoing thinking on COVID-19. He heads the research and data teams that produce daily analysis, risk assessment and critical data for the pharmaceutical industry, as well as the consulting team that focuses on disease prevention, workforce and demand healthcare microsimulation models. With more than 15 years of experience in the industry, he is a regular speaker at conferences and is frequently cited by major media publications and national radio and television programs. He is the author and podium presenter of research at numerous academic conferences such as ISPOR. Mr Ando also oversees our global comparative industry group which provide critical long-term forecast perspectives across all industries around the world, as well as our specialised global constructrion group. Mr. Ando holds a postgraduate degree from the University of Uppsala, Sweden, and an undergraduate degree from the University of Durham in the United Kingdom.

View Profile

Timothy Dall

A trained health economist, he brings more than 20 years of experience conducting research and policy analysis in the areas of health economics and outcomes, health workforce, health care delivery and disease cost and prevention. His work applies economic theory, statistical and econometric analysis, cost/benefit analysis, program evaluation, and computer modeling skills. Much of his work uses microsimulation modeling to address complex forecasting and policy issues. Applied research conducted by Mr. Dall supports strategic planning and advocacy work for governments, associations, life sciences companies, payers, provider networks, and non-profit organizations. He has published widely in peer-reviewed journals. Mr. Dall earned his Master of Science in Labor Economics at the University of Wisconsin-Madison, US, and his Bachelor of Science in Economics from Utah State University, Logan, Utah, US.

View Profile

Milena Izmirlieva

Ms. Izmirlieva heads the Life Sciences research team which comprises senior analysts, analysts and health economists covering developed and emerging markets worldwide. Since joining IHS Markit's Global Insight in 2003 as a research analyst in the Pharma Practice for Western European and Central and Eastern European markets, she has developed extensive knowledge of the healthcare systems and pharmaceutical markets of numerous countries in Europe, North America and various emerging markets. Her main areas of research interest are pricing and reimbursement and market access for originator drugs, the market dynamics for biosimilars and generics, heath system efficiency indicators and health system capacity, and forecasting of healthcare spending and pharmaceutical sales. Before joining IHS Markit, she worked in healthcare marketing communications for the EURO RSCG group in New York, US, and Sofia, Bulgaria, where she specialised in pharmaceutical and medical device companies. She holds a Master of Science degree in Communication with a focus on Science Writing from Iowa State University and a joint BA degree in Journalism and Mass Communication and International Relations from the American University in Bulgaria, and is in the process of completing a Master of Science degree in Health Economics, Policy and Management at the London School of Economics. Ms. Izmirlieva is a regular speaker at pharmaceutical conferences and is often interviewed about pharmaceutical-related issues in the media. She frequently presents peer-reviewed research at ISPOR and has a strong interest in pharmaceutical pricing and reimbursement developments and cost-containment strategies (including international reference pricing). Ms. Izmirlieva is a Fulbright scholarship recipient and member of the following honour societies: Phi Kappa Phi, Alfa Delta Sigma, and Kappa Tau Alfa.

View Profile

Cameron Lockwood

Mr. Lockwood collaborates with colleagues across Life Sciences and other teams to look at information and data rich solutions addressing client needs in the healthcare industry. Across diverse geographies, his work encompasses pricing and reimbursement, market access and policy-related topics relevant to pharmaceuticals, medical devices and other healthcare technologies. He oversees production of the “International Reference Pricing Guidebook,” IHS Markit’s comprehensive syndicated research offering detailing the nuances of IRP policy across 60+ countries. Cameron Lockwood joined the Life Sciences team in the London office in 2011, supporting the multiclient studies practice and he is currently based in the San Francisco Bay Area. Previously, he worked in the fields of healthcare communications and business intelligence. In addition to a graduate diploma in statistics through the University of Sheffield, he holds a Bachelor of Science in molecular biology from the University of Manchester, United Kingdom.

View Profile